469 related articles for article (PubMed ID: 20028024)
21. Beta-lactam congeners of orlistat as inhibitors of fatty acid synthase.
Zhang W; Richardson RD; Chamni S; Smith JW; Romo D
Bioorg Med Chem Lett; 2008 Apr; 18(7):2491-4. PubMed ID: 18343106
[TBL] [Abstract][Full Text] [Related]
22. Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.
Cho HJ; Jung MJ; Kwon Y; Na Y
Bioorg Med Chem Lett; 2009 Dec; 19(23):6766-9. PubMed ID: 19836231
[TBL] [Abstract][Full Text] [Related]
23. Tuning the acyclic ether moiety of anticancer agent AA005 with conformationally constrained fragments.
Liu HX; Shao F; Li GQ; Xun GL; Yao ZJ
Chemistry; 2008; 14(28):8632-9. PubMed ID: 18688824
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of indirubin-N'-glycosides and their anti-proliferative activity against human cancer cell lines.
Libnow S; Methling K; Hein M; Michalik D; Harms M; Wende K; Flemming A; Köckerling M; Reinke H; Bednarski PJ; Lalk M; Langer P
Bioorg Med Chem; 2008 May; 16(10):5570-83. PubMed ID: 18434163
[TBL] [Abstract][Full Text] [Related]
25. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
26. Total synthesis and comparative analysis of orlistat, valilactone, and a transposed orlistat derivative: Inhibitors of fatty acid synthase.
Ma G; Zancanella M; Oyola Y; Richardson RD; Smith JW; Romo D
Org Lett; 2006 Sep; 8(20):4497-500. PubMed ID: 16986934
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group.
Chen PC; Patil V; Guerrant W; Green P; Oyelere AK
Bioorg Med Chem; 2008 May; 16(9):4839-53. PubMed ID: 18397827
[TBL] [Abstract][Full Text] [Related]
28. Samarium(II) promoted stereoselective synthesis of antiproliferative cis-beta-alkoxy-gamma-alkyl-gamma-lactones.
Donadel OJ; Martín T; Martín VS; Padrón JM
Bioorg Med Chem Lett; 2007 Jan; 17(1):18-21. PubMed ID: 17055722
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of 1-(3',4',5'-trimethoxy) phenyl naphtho[2,1b]furan as a novel anticancer agent.
Srivastava V; Negi AS; Kumar JK; Faridi U; Sisodia BS; Darokar MP; Luqman S; Khanuja SP
Bioorg Med Chem Lett; 2006 Feb; 16(4):911-4. PubMed ID: 16297622
[TBL] [Abstract][Full Text] [Related]
30. Toward understanding how the lactone moiety of discodermolide affects activity.
Shaw SJ; Sundermann KF; Burlingame MA; Myles DC; Freeze BS; Xian M; Brouard I; Smith AB
J Am Chem Soc; 2005 May; 127(18):6532-3. PubMed ID: 15869264
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and cytotoxic activity of gamma-aryl substituted alpha-alkylidene-gamma-lactones and alpha-alkylidene-gamma-lactams.
Albrecht A; Koszuk JF; Modranka J; Rózalski M; Krajewska U; Janecka A; Studzian K; Janecki T
Bioorg Med Chem; 2008 May; 16(9):4872-82. PubMed ID: 18396404
[TBL] [Abstract][Full Text] [Related]
32. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
33. Synthetic analogues of the microtubule-stabilizing agent (+)-discodermolide: preparation and biological activity.
Gunasekera SP; Mickel SJ; Daeffler R; Niederer D; Wright AE; Linley P; Pitts T
J Nat Prod; 2004 May; 67(5):749-56. PubMed ID: 15165132
[TBL] [Abstract][Full Text] [Related]
34. Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity.
Kridel SJ; Axelrod F; Rozenkrantz N; Smith JW
Cancer Res; 2004 Mar; 64(6):2070-5. PubMed ID: 15026345
[TBL] [Abstract][Full Text] [Related]
35. Divergent synthesis of cytotoxic styryl lactones from D-xylose. The first total synthesis of (+)-crassalactone C.
Popsavin V; Benedeković G; Srećo B; Popsavin M; Francuz J; Kojić V; Bogdanović G
Org Lett; 2007 Oct; 9(21):4235-8. PubMed ID: 17867695
[TBL] [Abstract][Full Text] [Related]
36. [Applicability of coexpression networks analysis to anticancer drug targets discovery].
Ivliev AE; Rudneva VA; Sergeeva MG
Mol Biol (Mosk); 2010; 44(2):366-74. PubMed ID: 20586197
[TBL] [Abstract][Full Text] [Related]
37. Lead identification to generate isoquinolinedione inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment.
Mayer SC; Banker AL; Boschelli F; Di L; Johnson M; Kenny CH; Krishnamurthy G; Kutterer K; Moy F; Petusky S; Ravi M; Tkach D; Tsou HR; Xu W
Bioorg Med Chem Lett; 2008 Jun; 18(12):3641-5. PubMed ID: 18501599
[TBL] [Abstract][Full Text] [Related]
38. Practical, catalytic, asymmetric synthesis of beta-lactones via a sequential ketene dimerization/hydrogenation process: inhibitors of the thioesterase domain of fatty acid synthase.
Purohit VC; Richardson RD; Smith JW; Romo D
J Org Chem; 2006 Jun; 71(12):4549-58. PubMed ID: 16749788
[TBL] [Abstract][Full Text] [Related]
39. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
[TBL] [Abstract][Full Text] [Related]
40. A model-based approach to the in vitro evaluation of anticancer activity.
Del Bene F; Germani M; De Nicolao G; Magni P; Re CE; Ballinari D; Rocchetti M
Cancer Chemother Pharmacol; 2009 Apr; 63(5):827-36. PubMed ID: 18663447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
